Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-5-21
pubmed:abstractText
Integrin receptors serve as mechanical links between the cell and its structural environment. Using alpha(v)beta3 integrin expressed in K562 cells as a model system, the process by which the mechanical connection between alpha(v)beta3 and vitronectin develops was analyzed by measuring the resistance of these bonds to mechanical separation. Three distinct stages of activation, as defined by increases in the alpha(v)beta3-vitronectin binding strength, were defined by mutational, biochemical, and biomechanical analyses. Activation to the low binding strength stage 1 occurs through interaction with the vitronectin ligand and leads to the phosphorylation of Y747 in the beta3 subunit. Stage 2 is characterized by a 4-fold increase in binding strength and is dependent on stage1 and the phosphorylation of Y747. Stage 3 is characterized by a further 2.5-fold increase in binding strength and is dependent on stage 2 events and the availability of Y759 for interaction with cellular proteins. The Y747F mutant blocked the transition from stage 1 to stage 2, and the Y759F blocked the transition from stage 2 to stage 3. The data suggest a model for tension-induced activation of alpha(v)beta3 integrin.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-10069818, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-10419468, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-10464255, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-10548108, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-10614947, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-1419055, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-1555235, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-1894607, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-2411729, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-2477381, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-3115595, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-7510712, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-7521753, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-7542248, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-7679387, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-7721755, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-7721884, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-7759482, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-8458867, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-8621804, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-8689569, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-8940158, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-8970735, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-9019403, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-9247346, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-9353346, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-9362072, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-9478133, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-9556578, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-9575224, http://linkedlifedata.com/resource/pubmed/commentcorrection/11359918-9647659
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1059-1524
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1227-37
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:11359918-Antigens, CD, pubmed-meshheading:11359918-Antigens, CD29, pubmed-meshheading:11359918-Binding Sites, pubmed-meshheading:11359918-Cell Adhesion, pubmed-meshheading:11359918-Cell Separation, pubmed-meshheading:11359918-Flow Cytometry, pubmed-meshheading:11359918-Humans, pubmed-meshheading:11359918-Integrin beta3, pubmed-meshheading:11359918-K562 Cells, pubmed-meshheading:11359918-Kinetics, pubmed-meshheading:11359918-Ligands, pubmed-meshheading:11359918-Phosphorylation, pubmed-meshheading:11359918-Platelet Membrane Glycoproteins, pubmed-meshheading:11359918-Protein Binding, pubmed-meshheading:11359918-Receptors, Vitronectin, pubmed-meshheading:11359918-Stress, Mechanical, pubmed-meshheading:11359918-Tetradecanoylphorbol Acetate, pubmed-meshheading:11359918-Transfection, pubmed-meshheading:11359918-Vitronectin
pubmed:year
2001
pubmed:articleTitle
Activation of alpha(v)beta3-vitronectin binding is a multistage process in which increases in bond strength are dependent on Y747 and Y759 in the cytoplasmic domain of beta3.
pubmed:affiliation
Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. boettige@mail.med.upenn.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.